Anti-TIF1-Ab-Positive Dermatomyositis Linked to Higher Cancer Risk (CME/CE)

(MedPage Today) -- Testing for anti-transcriptional intermediary factor 1 antibody-positive (anti-TIF1-Ab) in early DM could guide cancer screening.

Source: MedPage Today Hematology/Oncology - December 13, 2018 Category: Hematology Source Type: news